Synergy of radiotherapy and a cancer vaccine for the treatment of HPV-associated head and neck cancer

Molecular Cancer Therapeutics

Volumn 14, Issue 6, 2015, Pages 1336-1345

  Mondini, Michele ^a   Nizard, Mevyn ^b   Tran, Thi ^b   Mauge, Laetitia ^b,c   Loi, Mauro ^a,d   Clémenson, Céline ^a   Dugue, Delphine ^a   Maroun, Pierre ^a,e   Louvet, Emilie ^f,g   Adam, Julien ^f,g   Badoual, Cécile ^b,c   Helley, Dominique ^b,c   Dransart, Estelle ^h   Johannes, Ludger ^h   Vozenin, Marie Catherine ^a,e,i   Perfettini, Jean Luc ^a,e,g   Tartour, Eric ^b,c   Deutsch, Eric ^a,e,g  

^a Institut Gustave Roussy   (France)

^b PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g SIRICSOCRATE   (France)

^h CNRS UMR3666   (France)

ⁱ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; CANCER VACCINE; CD31 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; PEPTIDE VACCINE; SHIGA TOXIN; SHIGA TOXIN B; UNCLASSIFIED DRUG; ACTIN; ANTIGEN; CHONDROITIN SULFATE PROTEOGLYCAN 4; PROTEOGLYCAN; STXB TOXIN; WART VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; BLOOD VESSEL PERMEABILITY; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG METASTASIS; MEMORY T LYMPHOCYTE; MOUSE; MULTIMODALITY CANCER THERAPY; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; TUMOR ENGRAFTMENT; VACCINATION; WART VIRUS; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; COMPLICATION; DRUG EFFECTS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEAD AND NECK NEOPLASMS; IMMUNOLOGY; METABOLISM; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; RADIATION RESPONSE; RADIOTHERAPY; SMOOTH MUSCLE;

ACTINS; ANIMALS; ANTIGENS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; COMBINED MODALITY THERAPY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEAD AND NECK NEOPLASMS; INTERCELLULAR ADHESION MOLECULE-1; MICE, INBRED C57BL; MUSCLE, SMOOTH; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PERICYTES; PROTEOGLYCANS; RADIOTHERAPY; SHIGA TOXINS; VACCINATION;

EID: 84942108093     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-14-1015     Document Type: Article

References (43)

1. De Vuyst H, Clifford G, Li N, Franceschi S. HPV infection in Europe. Eur J Cancer 2009;45:2632-9.
2. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 2013;40:187-93.
3. Arbyn M, de Sanjose S, Saraiya M, Sideri M, Palefsky J, Lacey C, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer 2012;131:1969-82.
4. Zaravinos A. An updated overview of HPV-associated head and neck carcinomas. Oncotarget 2014;5:3956-69.
5. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006;24:736-47.
6. Ang KK, Sturgis EM. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol 2012;22:128-42.
7. Lassen P. The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome. Radiother Oncol 2010;95:371-80.
8. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010;363:411-22.
9. Klebanoff CA, Acquavella N, Yu Z, Restifo NP. Therapeutic cancer vaccines: are we there yet? Immunol Rev 2011;239:27-44.
10. Harris TJ, Hipkiss EL, Borzillary S, Wada S, Grosso JF, Yen HR, et al. Radiotherapy augments the immune response to prostate cancer in a timedependent manner. Prostate 2008;68:1319-29.
11. Wu CY, Yang LH, Yang HY, Knoff J, Peng S, Lin YH, et al. Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors. Clin Cancer Res 2014;20:644-57.
12. Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013;105:256-65.
13. Levy A, Chargari C, Cheminant M, Simon N, Bourgier C, Deutsch E. Radiation therapy and immunotherapy: implications for a combined cancer treatment. Crit Rev Oncol Hematol 2013;85:278-87.
14. Schaue D, Ratikan JA, Iwamoto KS, McBride WH. Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys 2012;83:1306-10.
15. Welters MJ, Kenter GG, Piersma SJ, Vloon AP, Lowik MJ, Berends-van der Meer DM, et al. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine. Clin Cancer Res 2008;14:178-87.
16. Huang Y, Goel S, Duda DG, Fukumura D, Jain RK. Vascular normalization as an emerging strategy to enhance cancer immunotherapy. Cancer Res 2013;73:2943-8.
17. Vingert B, Adotevi O, Patin D, Jung S, Shrikant P, Freyburger L, et al. The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. Eur J Immunol 2006;36:1124-35.
18. Adotevi O, Vingert B, Freyburger L, Shrikant P, Lone YC, Quintin-Colonna F, et al. B subunit of Shiga toxin-based vaccines synergize with alphagalactosylceramide to break tolerance against self antigen and elicit antiviral immunity. J Immunol 2007;179:3371-9.
19. Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol 2012;36:1874-82.
20. Sandoval F, Terme M, Nizard M, Badoual C, Bureau MF, Freyburger L, et al. Mucosal imprinting of vaccine-induced CD8 (+) T cells is crucial to inhibit the growth of mucosal tumors. Sci Transl Med 2013;5:172ra20.
21. Fumagalli I, Dugue D, Bibault JE, Clemenson C, Vozenin MC, Mondini M, et al. Cytotoxic effect of lapatinib is restricted to human papillomaviruspositive head and neck squamous cell carcinoma cell lines. Onco Targets Ther 2015;8:335-45.
22. Haicheur N, Bismuth E, Bosset S, Adotevi O, Warnier G, Lacabanne V, et al. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J Immunol 2000;165:3301-8.
23. Mallard F, Johannes L. Shiga toxin B-subunit as a tool to study retrograde transport. Methods Mol Med 2003;73:209-20.
24. Badoual C, Hans S, Merillon N, Van Ryswick C, Ravel P, Benhamouda N, et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res 2013;73:128-38.
25. Johansson A, Ganss R. Remodeling of tumor stroma and response to therapy. Cancers (Basel) 2012;4:340-53.
26. Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011;21:193-215.
27. Ibla JC, Khoury J. Methods to assess tissue permeability. Methods Mol Biol 2013;1066:81-8.
28. Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep 2009;61:22-32.
29. Haicheur N, Benchetrit F, Amessou M, Leclerc C, Falguieres T, Fayolle C, et al. The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization. Int Immunol 2003;15:1161-71.
30. Maak M, Nitsche U, Keller L, Wolf P, Sarr M, Thiebaud M, et al. Tumorspecific targeting of pancreatic cancer with Shiga toxin B-subunit. Mol Cancer Ther 2011;10:1918-28.
31. Sadraeian M, Khoshnood Mansoorkhani MJ, Mohkam M, Rasoul-Amini S, Hesaraki M, Ghasemi Y. Prevention and inhibition of TC-1 cell growth in tumor bearing mice by HPV16 E7 protein in fusion with Shiga toxin Bsubunit from shigella dysenteriae. Cell J 2013;15:176-81.
32. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 2008;371:1695-709.
33. Goel S, Wong AH, Jain RK. Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. Cold Spring Harb Perspect Med 2012;2:a006486.
34. Heath VL, Bicknell R. Anticancer strategies involving the vasculature. Nat Rev Clin Oncol 2009;6:395-404.
35. Demaria S, Pilones KA, Vanpouille-Box C, Golden EB, Formenti SC. The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation. Radiat Res 2014;182:170-81.
36. Bellone M, Calcinotto A. Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes. Front Oncol 2013;3:231.
37. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003;300:1155-9.
38. Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, et al. Low-dose irradiation programs macrophage differentiation to an iNOS (+)/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell 2013;24:589-602.
39. Draghiciu O, Walczak M, Hoogeboom BN, Franken KL, Melief KJ, Nijman HW, et al. Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination. Int J Cancer 2014;134:859-72.
40. Galluzzi L, Kepp O, Kroemer G. Immunogenic cell death in radiation therapy. Oncoimmunology 2013;2:e26536.
41. Jahns J, Anderegg U, Saalbach A, Rosin B, Patties I, Glasow A, et al. Influence of low dose irradiation on differentiation, maturation and T-cell activation of human dendritic cells. Mutat Res 2011;709-710:32-9.
42. Quon H, Richmon JD. Treatment deintensification strategies for HPVassociated head and neck carcinomas. Otolaryngol Clin North Am 2012;45:845-61.
43. Tang C, Wang X, Soh H, Seyedin S, Cortez MA, Krishnan S, et al. Combining radiation and immunotherapy: a new systemic therapy for solid tumors? Cancer Immunol Res 2014;2:831-8.